Kairos Pharma, Ltd.
Asset & Liabilities Breakdown
Asset Breakdown FY2024
Total Assets: $5.8M
Liabilities Breakdown FY2024
Total Liabilities: $992.0K
Asset Breakdown
Total Assets: $5.8M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $1.3M | 22.1% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $0 | 0.0% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $222.0K | 3.8% |
| Other Assets | $4.3M | 74.1% |
Liabilities Breakdown
Total Liabilities: $992.0K
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $0 | 0.0% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $992.0K | 100.0% |